EDIL3 and breast cancer: Lee et al., through Liquid Chromatography-Tandem Mass Spectrometry (LC–MS/MS), identified 270 exosome proteins in invasive BC cell lines, unveiling the diagnostic biomarker Epidermal Growth Factor-like repeats and Discoidin I-Like Domains 3 (EDIL3) correlated with metastasis [147].